ロード中...
Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is an incurable cancer resistant to traditional treatments, although a limited number of early-stage patients can undergo radical resection. Immunotherapies for the treatment of haematological malignancies as well as solid tumours have been substantially impro...
保存先:
| 出版年: | Mol Cancer |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7023714/ https://ncbi.nlm.nih.gov/pubmed/32061257 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-020-01151-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|